These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 26548839)
1. Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40. Wang J; Wang L; Xiang Y; Ricklin D; Lambris JD; Chen G Clin Immunol; 2016 Jan; 162():37-44. PubMed ID: 26548839 [TBL] [Abstract][Full Text] [Related]
3. Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy. Zhang Y; Shao D; Ricklin D; Hilkin BM; Nester CM; Lambris JD; Smith RJ Immunobiology; 2015 Aug; 220(8):993-8. PubMed ID: 25982307 [TBL] [Abstract][Full Text] [Related]
4. Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria. Risitano AM; Ricklin D; Huang Y; Reis ES; Chen H; Ricci P; Lin Z; Pascariello C; Raia M; Sica M; Del Vecchio L; Pane F; Lupu F; Notaro R; Resuello RR; DeAngelis RA; Lambris JD Blood; 2014 Mar; 123(13):2094-101. PubMed ID: 24497537 [TBL] [Abstract][Full Text] [Related]
5. Complement C3 inhibitor Cp40 attenuates xenoreactions in pig hearts perfused with human blood. Abicht JM; Kourtzelis I; Reichart B; Koutsogiannaki S; Primikyri A; Lambris JD; Chavakis T; Holdt L; Kind A; Guethoff S; Mayr T Xenotransplantation; 2017 Jan; 24(1):. PubMed ID: 27677785 [TBL] [Abstract][Full Text] [Related]
6. Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primates. Hughes S; Gumas J; Lee R; Rumano M; Berger N; Gautam AK; Sfyroera G; Chan AL; Gnanaguru G; Connor KM; Kim BJ; Dunaief JL; Ricklin D; Hajishengallis G; Yancopoulou D; Reis ES; Mastellos DC; Lambris JD Clin Immunol; 2020 May; 214():108391. PubMed ID: 32229292 [TBL] [Abstract][Full Text] [Related]
7. Complement-Dependent Mechanisms and Interventions in Periodontal Disease. Hajishengallis G; Kajikawa T; Hajishengallis E; Maekawa T; Reis ES; Mastellos DC; Yancopoulou D; Hasturk H; Lambris JD Front Immunol; 2019; 10():406. PubMed ID: 30915073 [TBL] [Abstract][Full Text] [Related]
8. Over-expression of heme oxygenase-1 does not protect porcine endothelial cells from human xenoantibodies and complement-mediated lysis. Zhang C; Wang L; Zhong S; Wang XX; Xiang Y; Chen S; Chen G J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):102-106. PubMed ID: 23392716 [TBL] [Abstract][Full Text] [Related]
10. TNF-α promotes human antibody-mediated complement-dependent cytotoxicity of porcine endothelial cells through downregulating P38-mediated Occludin expression. Gao H; Cao M; Chen P; Cooper DKC; Zhao Y; Wei L; Xu J; Cai Z; Zeng C; Luan S; Mou L Cell Commun Signal; 2019 Jul; 17(1):75. PubMed ID: 31307477 [TBL] [Abstract][Full Text] [Related]
11. Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention. Mastellos DC; Yancopoulou D; Kokkinos P; Huber-Lang M; Hajishengallis G; Biglarnia AR; Lupu F; Nilsson B; Risitano AM; Ricklin D; Lambris JD Eur J Clin Invest; 2015 Apr; 45(4):423-40. PubMed ID: 25678219 [TBL] [Abstract][Full Text] [Related]
12. RNA interference of GGTA1 physiological and immune functions in immortalized porcine aortic endothelial cells. Han W; Zhou J; Li X; Wang J; Li J; Zhang Z; Yang Z; Wang D; Tao K; Dou K J Surg Res; 2013 Nov; 185(1):410-8. PubMed ID: 23809180 [TBL] [Abstract][Full Text] [Related]
13. Complement inhibition in a xenogeneic model of interactions between human whole blood and porcine endothelium. Kourtzelis I; Ferreira A; Mitroulis I; Ricklin D; Bornstein SR; Waskow C; Lambris JD; Chavakis T Horm Metab Res; 2015 Jan; 47(1):36-42. PubMed ID: 25350518 [TBL] [Abstract][Full Text] [Related]
14. New Analogs of the Complement C3 Inhibitor Compstatin with Increased Solubility and Improved Pharmacokinetic Profile. Berger N; Alayi TD; Resuello RRG; Tuplano JV; Reis ES; Lambris JD J Med Chem; 2018 Jul; 61(14):6153-6162. PubMed ID: 29920096 [TBL] [Abstract][Full Text] [Related]
15. Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application. Hajishengallis G; Hajishengallis E; Kajikawa T; Wang B; Yancopoulou D; Ricklin D; Lambris JD Semin Immunol; 2016 Jun; 28(3):285-91. PubMed ID: 27021500 [TBL] [Abstract][Full Text] [Related]